HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
SRE holding history
Sempra in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRE overviewAll 13F holders of SREFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,144
- Value
- $198.8K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,144 | $198.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 2,144 | $208.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 2,144 | $189.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,144 | $192.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 2,144 | $162.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 2,144 | $153.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 2,144 | $188.1K | <0.1% | −12−0.6% | Reduced | Holders |
| Q3 2024 | 2,156 | $180.3K | <0.1% | +12+0.6% | Added | Holders |
| Q2 2024 | 2,144 | $163.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,144 | $154.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,144 | $160.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,144 | $145.9K | <0.1% | 00.0% | UnchangedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 1,072 | $156.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,072 | $162.0K | <0.1% | −7−0.6% | Reduced | Holders |
| Q4 2022 | 1,079 | $166.7K | <0.1% | +7+0.7% | Added | Holders |
| Q3 2022 | 1,072 | $161.0K | <0.1% | +57+5.6% | Added | Holders |
| Q2 2022 | 1,015 | $153.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,015 | $171.0K | <0.1% | −67−6.2% | Reduced | Holders |
| Q4 2021 | 1,082 | $143.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,082 | $137.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,082 | $143.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 1,082 | $143.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.